Roy Brooks
Obstetrics & Gynecology · Silver Spring, MDNPI 1780602979
Payments from drug & device makers
Across 113 payments — averaging $40.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$3K
- AbbVie$740
- Astellas Pharma US Inc$177
- Exeltis, USA Inc.$171
- Daiichi Sankyo Inc.$122
- Pfizer$118
- plus $623 from 18 others
What the payments were for
- Consulting fees$140%
- Speaking & faculty fees$2,63857%
- Food & beverage$1,93942%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 2 | $2,638 |
| AbbVie(2 entities) | 45 | $740 |
| Astellas Pharma US Inc | 8 | $177 |
| Exeltis, USA Inc. | 9 | $171 |
| Daiichi Sankyo Inc. | 5 | $122 |
| Pfizer | 6 | $118 |
| Avion Pharmaceuticals | 8 | $116 |
| Bayer | 5 | $93 |
| Myovant Sciences Inc. | 4 | $76 |
| Aspira Women's Health Inc | 3 | $53 |
| Mayne Pharma Commercial LLC | 2 | $33 |
| Vertical Pharmaceuticals, LLC | 2 | $33 |
| Therapeuticsmd, Inc. | 2 | $30 |
| Mission Pharmacal Company | 2 | $27 |
| Lilly USA, LLC | 1 | $22 |
| Evofem Biosciences, Inc. | 1 | $21 |
| Cumberland Pharmaceuticals, Inc. | 1 | $19 |
| Exact Sciences | 1 | $17 |
| Minerva Surgical, Inc | 1 | $17 |
| Boston Scientific | 1 | $15 |
| Coopersurgical, Inc. | 1 | $14 |
| Gilead | 1 | $13 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$1,438
- JADA SYSTEM$1,200
How this compares
$4,590 in reported general payments places this provider in the 85th percentile of 842 obstetrics & gynecology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 11 | $336 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Silver Spring
- Otis StittSilver Spring$641K
- Sweta PatelSilver Spring$24K
- Ifeyinwa StittSilver Spring$19K
- Darryn BandSilver Spring$8K
- Tamara CoatesSilver Spring$6K
- Ashleigh BouchelionSilver Spring$6K
- Colleen McCormickBaltimore$1.9M
- Jenell ColemanBaltimore$1.2M
- Issam DayaTowson$940K
- Danielle ShillerBaltimore$473K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.